Journal article icon

Journal article

Cannabinoid type 1 receptor antagonists for smoking cessation.

Abstract:

Selective type 1 cannabinoid (CB1) receptor antagonists may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. They also seeks to address many smokers' reluctance to persist with a quit attempt because of concerns about weight gain. To determine whether selective CB1 receptor antagonists (currently rimonabant and taranabant) increase the numbers of people stopping smoking To assess their effects on weight ...

Expand abstract

Actions


Authors


Journal:
Cochrane database of systematic reviews (Online)
Volume:
3
Publication date:
2011-01-01
EISSN:
1469-493X
Source identifiers:
214833
Language:
English
Pubs id:
pubs:214833
UUID:
uuid:4a22309e-7179-4ea2-aa5a-2e84826f2bfc
Local pid:
pubs:214833
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP